Scholarlink

<p>Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA), but patient responses are highly variable. Macrophages are central drivers of RA inflammation, yet how monocyte/macrophage heterogeneity and transcriptional programs influence MTX responsiveness remains unclear. Single-cell RNA sequencing was performed on peripheral blood mononuclear cells from MTX-responsive and MTX-unresponsive RA patients to define immune composition and macrophage-like monocyte subsets. Polarization states were assessed using gene-signature scoring and pseudotime analysis. The role of inhibitor of differentiation 2 (ID2) was examined in LPS-stimulated RA patient–derived macrophages using gain- and loss-of-function approaches, cytokine assays and chromatin immunoprecipitation assays. Although overall immune cell distributions were similar between groups, macrophage-like monocytes from MTX-unresponsive patients exhibited higher M1 polarization scores. PLBD1⁺ and CDKN1A⁺ macrophage-like monocytes were enriched in MTX-unresponsive patients, whereas RLIM⁺ macrophage-like monocytes were reduced. Integrative analyses identified ID2 as a regulator associated with MTX resistance. ID2 expression was elevated in macrophage-like monocytes from MTX-unresponsive patients and positively correlated with M1 polarization. In vitro, MTX suppressed ID2 expression and inflammatory activation. ID2 knockdown reduced pro-inflammatory responses, whereas overexpression attenuated the inhibitory effects of MTX. ID2 was found to regulate EEF1A1 transcription. ID2 promotes pro-inflammatory macrophage polarization and may contribute to MTX resistance in RA.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

ID2 Regulates Macrophage Polarization and Mediates Methotrexate Responsiveness in Rheumatoid Arthritis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月22日

查看全文
  • Lu Ye,
  • Xiaomei Wang,
  • Huaxiang Wu,
  • Weihong Xu

摘要

Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA), but patient responses are highly variable. Macrophages are central drivers of RA inflammation, yet how monocyte/macrophage heterogeneity and transcriptional programs influence MTX responsiveness remains unclear. Single-cell RNA sequencing was performed on peripheral blood mononuclear cells from MTX-responsive and MTX-unresponsive RA patients to define immune composition and macrophage-like monocyte subsets. Polarization states were assessed using gene-signature scoring and pseudotime analysis. The role of inhibitor of differentiation 2 (ID2) was examined in LPS-stimulated RA patient–derived macrophages using gain- and loss-of-function approaches, cytokine assays and chromatin immunoprecipitation assays. Although overall immune cell distributions were similar between groups, macrophage-like monocytes from MTX-unresponsive patients exhibited higher M1 polarization scores. PLBD1⁺ and CDKN1A⁺ macrophage-like monocytes were enriched in MTX-unresponsive patients, whereas RLIM⁺ macrophage-like monocytes were reduced. Integrative analyses identified ID2 as a regulator associated with MTX resistance. ID2 expression was elevated in macrophage-like monocytes from MTX-unresponsive patients and positively correlated with M1 polarization. In vitro, MTX suppressed ID2 expression and inflammatory activation. ID2 knockdown reduced pro-inflammatory responses, whereas overexpression attenuated the inhibitory effects of MTX. ID2 was found to regulate EEF1A1 transcription. ID2 promotes pro-inflammatory macrophage polarization and may contribute to MTX resistance in RA.